← Back to patent-cliff list
CAS 13956-29-1
(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol
Codes：CANN-002
Application context (from source-drug indications)
结节性脑硬化大麻二酚Dravet综合征大麻二酚Lennox Gastaut综合征大麻二酚精神病大麻二酚Ⅲ型黏多糖贮积症大麻二酚系统性硬皮病大麻二酚
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 大麻二酚Cannabidiol | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylic acid→(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol→3,5-dinitrobenzoyl chloride→(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diyl bis(3,5-dinitrobenzoate)
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.